Loading...
 
Toggle Health Problems and D

Sleep Apena patents are 5X more likely to have a COVID-19 infection requiring hospitalization - Sept 28, 2020

Sleep apnoea is a risk factor for severe COVID-19

medRxiv doi: https://doi.org/10.1101/2020.09.26.20202051. preprint
Satu Strausz, Tuomo Kiiskinen, Martin Broberg, Sanni Ruotsalainen, Jukka Koskela, Adel Bachour, Aarno Palotie, Tuula Palotie, Samuli Ripatti, Hanna M Ollila
Image

Vitamin D Life

Many health problems, such as Sleep Apnea in this case, which are associated with low vitamin D are also risk Factors for COVID-19


High Risk category listing contains the following

49 items in High Risk Category (below)

see also
  Overview Dark Skin
  Overview Seniors
  Overview Obesity
  Overview Pregnancy
  Overview Deficiency
   Shut-in category which has 32 items
   Middle East category which has 133 items

Sleep category starts with

70 items in sleep category

See also

- - - - - - - - -


Diabetes category starts with the following

454 items In Diabetes category

see also Overview Diabetes and vitamin D  Overview Metabolic Syndrome and vitamin D

Autoimmune category listing has 164 items along with related searches

T1 diabetes OR type1 diabetes in title 107 as of April 2018
prediabetes OR prediabetic 336 items as of Jan 2018
Search Vitamin D Life for Peripheral Neuropathy 238 items April 2018
- - - - - - - - -


 Download the PDF from Vitamin D Life

Objective: To investigate if obstructive sleep apnoea (OSA) is an independent risk factor for severe COVID-19. To examine whether the risk for contracting COVID-19 is elevated among OSA patients.

Design and setting: Registry based retrospective case-control study using Finnish nationwide health registries and the FinnGen Study cohort. Participants: Information regarding OSA diagnosis and COVID-19 infection was extracted from the FinnGen study (N=260,405) with a total of 305 patients who had a recorded PCR-validated COVID-19 infection including 26 (8.5%) individuals who were also OSA patients. Severe COVID-19 (N=83, 27.2%) was defined as an infection requiring hospitalization. Among the hospitalized individuals there were 16 (19.3%) with OSA diagnosis. In addition, we also included in our analysis previously reported risk factors for both severe COVID-19 or risk factors and comorbidities for OSA from FinnGen. Main outcome measures: OSA diagnosis, information concerning COVID-19 infection such as hospitalization, were derived from Finnish National Hospital Discharge Registry, Causes of Death Registry and the National Infectious Diseases Registry.

Results: We show that OSA is a risk factor for COVID-19 hospitalization independent from age, sex, body mass index (BMI), hypertension, diabetes, coronary heart disease (CHD), asthma and chronic obstructive pulmonary disease (COPD), (p-unadjusted=1.04x10 -4, OR-adjusted=5.24 [95%CI 1.33 to 23.43], p-adjusted=0.022). OSA was not associated with the risk of contracting COVID-19 (p=0.49).

Conclusion: While an OSA patients risk of contracting COVID-19 is the same as non-OSA individuals, the OSA patients have a five-fold risk to be hospitalized when affected by COVID-19 than non-OSA individuals. Our findings suggest that, in assessment of patients with suspected or confirmed COVID-19 infection, OSA needs to be recognized as one of the comorbidity risk factors for developing a severe form of the disease.


Created by admin. Last Modification: Tuesday September 29, 2020 20:32:06 GMT-0000 by admin. (Version 8)

Attached files

ID Name Comment Uploaded Size Downloads
14378 Sleep Apnea COVID-19.jpg admin 29 Sep, 2020 20:09 102.77 Kb 67
14377 Sleep apnoea is a risk factor for severe COVID-19 preprint.pdf PDF 2020 admin 29 Sep, 2020 20:09 422.63 Kb 25
See any problem with this page? Report it (FINALLY WORKS)